Growth in spending on substance use disorder treatment services for the privately insured population

Drug and Alcohol Dependence
Cindy Parks ThomasTami L Mark

Abstract

Approximately 8% of individuals with private health insurance in the United States have substance use disorders (SUDs), but in 2009 only 0.4% of all private insurance spending was on SUDs. The objective of this study was to determine if changes that occurred between 2009 and 2012 - such as more generous SUD benefits, an epidemic of opioid use disorders, and slow recovery from a recession - were associated with greater use of SUD treatment. Data were from the 2004-2012 Truven Health Analytics MarketScan(®) Commercial Claims and Encounters Database. This database is representative of individuals with private insurance in the United States. Per enrollee use of and spending on SUD treatment was determined and compared with spending on all health care services. Trends were examined for inpatient care, outpatient care, and prescription medications. During the 2009-2012 time period, use of and spending on SUD services increased compared with all diagnoses. Two-thirds of the increase was driven by higher growth rates in outpatient use and prices. Despite the high growth rates, SUD treatment penetration rates remained low. As of 2012, only 0.6% of individuals with private insurance used SUD outpatient services, 0.2% filled SUD medicatio...Continue Reading

References

Nov 4, 1995·Journal of Health Economics·C J Ruhm
Jul 31, 2002·Journal of Health Economics·Christopher J Ruhm, William E Black
Jul 26, 2008·Journal of Health Economics·Kerwin Kofi Charles, Philip Decicca
Nov 13, 2009·Administration and Policy in Mental Health·Craig LandryKenneth B Wells
Aug 16, 2011·The International Journal on Drug Policy·Cláudia Costa StortiLinda Montanari
Mar 23, 2012·Drug and Alcohol Dependence·Tami L Mark, Rita Vandivort-Warren
May 29, 2012·Addictive Behaviors·Ganga VijayasiriKathleen M Rospenda
Mar 2, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·Susan H BuschColleen L Barry
Nov 22, 2013·Alcoholism, Clinical and Experimental Research·Nina MuliaRalph Catalano
Sep 30, 2014·The American Journal of Psychiatry·Ezra GolbersteinEllen Meara

❮ Previous
Next ❯

Citations

Mar 16, 2017·Journal of Psychoactive Drugs·Hannah K Knudsen, Jamie L Studts
Dec 1, 2017·Journal of Addiction Medicine·Julie M DonohueHaiden A Huskamp
May 2, 2019·Addiction Science & Clinical Practice·Paul J JoudreyMarcus A Bachhuber
Jan 12, 2021·International Journal of Mental Health and Addiction·Rachel R TamblingCarissa D'Aniello

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Mental Health Policy and Economics
David R McKusickJames Genuardi
Psychiatric Services : a Journal of the American Psychiatric Association
Ilse R WiechersR Rosenheck
© 2022 Meta ULC. All rights reserved